Talphera Inc banner

Intrinsic Value

The intrinsic value of Talphera Inc (TLPH) under the Base Case is 0.2 USD per share. Compared with the current market price of 1.05 USD, the stock appears Overvalued by 81% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

TLPH Intrinsic Value
$0.2
Overvaluation 81%
Intrinsic Value
Price $1.05

TLPH is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor TLPH
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0.16
Get notified when the price drops into your buy zone
Current Price $1.05
Intrinsic Value $0.2
Margin of Safety 20% $0.16
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to TLPH

Fundamental Analysis

What Talphera Does

Pharmaceuticals Health Care

Talphera is a specialty pharmaceutical company focused on acute care, especially pain control and sedation in hospital and other closely monitored medical settings. It develops and commercializes prescription drug products designed for use by clinicians, where fast onset, controlled dosing, and simple administration matter more than everyday retail convenience.

Headquarters
United States of America US
Employees
12
IPO date
Feb 11, 2011
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Talphera Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

TLPH Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TLPH stock?

The intrinsic value for Talphera Inc (TLPH) under the Base Case is 0.2 USD.

Is TLPH stock undervalued or overvalued?

Compared with the current market price of 1.05 USD, the stock appears Overvalued by 81% .

Back to Top